The $1.7 trillion revenue prescription drug industry has a relatively robust immunity to tariffs. Last Wednesday, when U.S.

Big Pharma hates 340b because it costs them money, but so far both Republicans and Democrats have favored the program because it’s helped so many people. The scary part here though is the judge ...